Free Trial

Neuronetics (STIM) Competitors

Neuronetics logo
$3.52 +0.02 (+0.43%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STIM vs. KMTS, SIBN, IRMD, CBLL, EMBC, BBNX, AVNS, BVS, KIDS, and RXST

Should you be buying Neuronetics stock or one of its competitors? The main competitors of Neuronetics include Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), Bioventus (BVS), OrthoPediatrics (KIDS), and RxSight (RXST). These companies are all part of the "medical equipment" industry.

Neuronetics vs. Its Competitors

Kestra Medical Technologies (NASDAQ:KMTS) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

In the previous week, Kestra Medical Technologies had 3 more articles in the media than Neuronetics. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 1 mentions for Neuronetics. Kestra Medical Technologies' average media sentiment score of 0.15 beat Neuronetics' score of 0.00 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Neuronetics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

53.6% of Neuronetics shares are owned by institutional investors. 8.7% of Neuronetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Kestra Medical Technologies presently has a consensus price target of $27.50, suggesting a potential upside of 80.45%. Neuronetics has a consensus price target of $5.50, suggesting a potential upside of 56.47%. Given Kestra Medical Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Kestra Medical Technologies is more favorable than Neuronetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Neuronetics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Kestra Medical Technologies has higher earnings, but lower revenue than Neuronetics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical TechnologiesN/AN/AN/AN/AN/A
Neuronetics$74.89M3.10-$43.71M-$1.31-2.68

Kestra Medical Technologies has a net margin of 0.00% compared to Neuronetics' net margin of -53.67%. Kestra Medical Technologies' return on equity of 0.00% beat Neuronetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical TechnologiesN/A N/A N/A
Neuronetics -53.67%-174.15%-38.41%

Summary

Kestra Medical Technologies beats Neuronetics on 8 of the 11 factors compared between the two stocks.

Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STIM vs. The Competition

MetricNeuroneticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$232.11M$6.82B$5.58B$9.03B
Dividend YieldN/A1.29%5.25%4.03%
P/E Ratio-2.6825.6027.1820.17
Price / Sales3.1090.30415.50184.26
Price / CashN/A20.6637.0657.97
Price / Book6.174.788.085.60
Net Income-$43.71M$174.76M$3.16B$248.50M
7 Day Performance3.23%1.57%3.64%5.07%
1 Month Performance-7.26%0.59%3.78%7.53%
1 Year Performance90.00%14.24%34.08%21.54%

Neuronetics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STIM
Neuronetics
1.6358 of 5 stars
$3.52
+0.4%
$5.50
+56.5%
+92.3%$232.11M$74.89M-2.68180News Coverage
KMTS
Kestra Medical Technologies
N/A$14.75
-5.9%
$27.50
+86.4%
N/A$804.64M$52.64M0.00300News Coverage
SIBN
SiBone
4.0437 of 5 stars
$18.01
-2.5%
$22.50
+24.9%
+37.1%$787.09M$167.18M-28.14350News Coverage
IRMD
iRadimed
4.6171 of 5 stars
$59.02
-4.5%
$72.00
+22.0%
+37.0%$785.79M$73.24M38.08110
CBLL
CeriBell
2.3967 of 5 stars
$17.20
-9.1%
$32.14
+86.9%
N/A$684.19M$65.44M0.00N/AInsider Trade
EMBC
Embecta
4.5607 of 5 stars
$10.03
-2.8%
$19.33
+92.8%
-9.7%$603.13M$1.08B11.142,100News Coverage
Positive News
BBNX
Beta Bionics
N/A$13.40
-0.9%
$23.44
+75.0%
N/A$586.18M$65.12M0.00294
AVNS
AVANOS MEDICAL
1.5341 of 5 stars
$11.87
-3.9%
N/A-36.2%$571.11M$687.80M-1.422,227News Coverage
Negative News
BVS
Bioventus
3.3063 of 5 stars
$6.82
-2.8%
$13.75
+101.6%
+16.2%$560.22M$567.70M-11.181,200News Coverage
Positive News
Analyst Forecast
KIDS
OrthoPediatrics
4.335 of 5 stars
$21.24
-5.5%
$35.83
+68.7%
-31.6%$545.96M$204.73M-12.14200News Coverage
Positive News
RXST
RxSight
2.3506 of 5 stars
$12.43
-4.8%
$37.90
+204.9%
-86.1%$530.31M$139.93M-18.55220Trending News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:STIM) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners